May 28, 2010, Seattle--Researchers analyzing 2.5 million screening mammograms performed on nearly one million women found discrimination of cancerous from non-cancerous lesions improved over a nine-year period. Results of the study are published in the online edition of the journal Radiology.
"To our knowledge, this is the first study of time trends for performance measures in a large representative sample of women undergoing screening mammography in the United States," said lead author Laura E. Ichikawa, MS, a senior biostatistician at Group Health Research Institute.
The research team examined data from six mammography registries in the Breast Cancer Surveillance Consortium (BCSC). The data included 2,542,049 screening mammograms of 971,364 women (age 40 to 79) performed at health care facilities throughout the country between 1996 and 2004.
Each of the women included in the study had at least one prior mammogram and at least nine months in between mammography exams. Cancer registries and pathology databases were used to identify breast cancers that occurred within one year of any mammogram included in the study.
"We found universal trends that breast imagers are increasing their ability to detect and intercept breast cancer before a lump is felt by a woman," said study co-author R. James Brenner, MD, professor of clinical radiology at the University of California, San Francisco.
Analysis of the radiologists' performance in interpreting the mammograms over the nine-year time period revealed an increase in the recall rate, or mammograms resulting in patients being called back for further evaluation, from 6.7 percent (10,779 of 160,329 mammograms) in 1996 to 8.6 percent (24,630 of 285,286) in 2004.
The sensitivity rate, or the ability of radiologists to identify cancer when present, increased from 71.4 percent in 1996 to 83.8 percent in 2004. The specificity rate, or the degree to which radiologists correctly identified non-cancerous lesions, decreased from 93.6 percent in 1996 to 91.7 percent in 2004.
According to Ms. Ichikawa, the increase in the cancer detection rate outweighed the increase in false-positive test results over the nine-year time period, for a positive net effect.
"This is good news for women and for radiology that we have seen a net improvement in how radiologists interpret mammograms," she said. "Radiologists are doing a better job of discriminating cancer from non-cancer."
A total of 12,498 invasive cancers and non-invasive cancers were diagnosed. An invasive cancer is a cancer that has spread beyond the layer of tissue where it developed and is growing into surrounding, healthy tissues. Overall, 78.7 percent of cancers included in the study were invasive.
Most mammograms included in the study were film studies. Ms. Ichikawa said future studies could focus on time trends of radiologists' interpretive performance when reading digital mammograms. Digital mammography, which was just beginning to be adopted in health care institutions toward the end of this study, is now available in approximately half of all mammography facilities in the country.
Collaborating with Ms. Ichikawa and Dr. Brenner were William E. Barlow, PhD, of Group Health Research Institute and Cancer Research and Biostatistics (CRAB); Melissa L. Anderson, MS, of Group Health Research Institute; Stephen Taplin, MD, MPH, of the National Cancer Institute; and Berta M. Geller, EdD, of the University of Vermont.
Radiology is edited by Herbert Y. Kressel, MD, of Harvard Medical School, in Boston, and owned and published by the Radiological Society of North America, Inc. RSNA is an association of more than 44,000 radiologists, radiation oncologists, medical physicists and related scientists committed to excellence in patient care through education and research. The Society is based in Oak Brook, Ill. For patient-friendly information on mammography, visit RadiologyInfo.org.
Breast Cancer Surveillance Consortium
The Breast Cancer Surveillance Consortium (BCSC) is a research resource for studies designed to assess the delivery and quality of breast cancer screening and related patient outcomes in the United States. The BCSC is a collaborative network of seven mammography registries with linkages to tumor and/or pathology registries. The network is supported by a central Statistical Coordinating Center. Currently, the Consortium's database contains information on 7,521,000 mammographic examinations, 2,017,869 women, and 86,700 cancer cases (72,800 invasive cancers and 13,800 in situ).
Group Health Research Institute
Founded in 1947, Group Health Cooperative is a Seattle-based, consumer-governed, nonprofit health care system. Group Health Research Institute (www.grouphealthresearch.org) changed its name from Group Health Center for Health Studies on September 8, 2009. Since 1983, the Institute has conducted nonproprietary public-interest research on preventing, diagnosing, and treating major health problems. Government and private research grants provide its main funding.